Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Rühl

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cellular and Molecular Life Sciences : CMLS|May 6, 2020
Vaccination against the Epstein-Barr virusJulia Rühl, Carol S Leung, Christian Münz
Mbio|January 17, 2019
MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control <i>In Vivo</i>Anita Murer, Julia Rühl, Andrea Zbinden, et al.
The Journal of Clinical Investigation|May 2, 2019
Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomasJulia Rühl, Carmen Citterio, Christine Engelmann, et al.
Nature Communications|June 6, 2024
KSHV infection of B cells primes protective T cell responses in humanized miceNicole Caduff, Lisa Rieble, Michelle Böni, et al.
European Journal of Immunology|September 19, 2020
Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15Hana Zdimerova, Anita Murer, Christine Engelmann, et al.
European Journal of Immunology|December 21, 2021
Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor LangerinLydia Bellmann, Helen Strandt, Claudia Zelle-Rieser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2018
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized MicePratiksha Gulati, Julia Rühl, Abhilash Kannan, et al.
Life Science Alliance|June 25, 2020
EBV renders B cells susceptible to HIV-1 in humanized miceDonal McHugh, Renier Myburgh, Nicole Caduff, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cellular and Molecular Life Sciences : CMLS|May 6, 2020
Vaccination against the Epstein-Barr virusJulia Rühl, Carol S Leung, Christian Münz
Mbio|January 17, 2019
MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control <i>In Vivo</i>Anita Murer, Julia Rühl, Andrea Zbinden, et al.
The Journal of Clinical Investigation|May 2, 2019
Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomasJulia Rühl, Carmen Citterio, Christine Engelmann, et al.
Nature Communications|June 6, 2024
KSHV infection of B cells primes protective T cell responses in humanized miceNicole Caduff, Lisa Rieble, Michelle Böni, et al.
European Journal of Immunology|September 19, 2020
Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15Hana Zdimerova, Anita Murer, Christine Engelmann, et al.
European Journal of Immunology|December 21, 2021
Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor LangerinLydia Bellmann, Helen Strandt, Claudia Zelle-Rieser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2018
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized MicePratiksha Gulati, Julia Rühl, Abhilash Kannan, et al.
Life Science Alliance|June 25, 2020
EBV renders B cells susceptible to HIV-1 in humanized miceDonal McHugh, Renier Myburgh, Nicole Caduff, et al.
Pageof 1